Isosorbide mononitrate (ISMN) is the active metabolite of ISDN and is primarily used in the management of chronic stable angina. It is not FDA-approved for treating heart failure. It has high ...
Learn everything you need to know about Isosorbide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...
New York, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Isosorbide Market Size, Share & Trends Analysis Report By End Use, By Application, By Region And ...
(MENAFN- GlobeNewsWire - Nasdaq) Growing Demand for Bio-Based Alternatives and Increasing Use in Bio-Polymer Manufacturing Anticipated to Drive Isosorbide Market Share Wilmington, Delaware, ...
Sublingual isosorbide dinitrate, 5 mg, combined with oral propranolol, 40 mg, was given four times daily for six weeks to 23 patients with angina pectoris. The effects were compared with those of ...
DUBLIN, June 23, 2023 /PRNewswire/ -- The "Isosorbide Market Share, Size, Trends, Industry Analysis Report, By Application, By End-Use, By Region, Segment Forecast, 2023-2032" report has been added to ...
In the quest to replace fossil-based feedstocks for cost-effective equivalents derived from renewable resources, isosorbide has emerged as a promising player. A sustainable and non-toxic diol for ...
The catalytic dehydration of sorbitol to isosorbide has emerged as a critical process in the transition towards sustainable chemical manufacturing. This reaction transforms sorbitol, a readily ...
The Iowa Corn Promotion Board (ICPB), NJIT and University of Sao Paulo today announced a joint agreement for licensing four pending patents on a safe, building block chemical derived from corn known ...
The global isosorbide market size is expected to reach USD 1.30 billion by 2030, as per the report., expanding at a CAGR of 9.1% from 2022 to 2030. The market is driven by favorable regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results